Over the past decades, controlled drug delivery system remains as one of the most important area in medicine for various diseases. We have developed a new electrochemical control drug release system by combining colloid electrochemistry and electro-responsive microcapsules. The pulsed electrode potential modulation led to the appearance of two processes available for the time-resolved registration in colloid microenvironment: change of the electronic charge of microparticles (from 0.5 ms to 0. 
Over the past decades, controlled drug delivery system remains as one of the most important area in medicine for various applications such as cancer treatments, metabolic disorders, autoimmune diseases and chronic diseases [1] [2] [3] . Many different triggering approaches including pH-switch [4] , temperatureswitch [5, 6] , magnetic field [7] , and electrical stimulation [8] [9] [10] [11] [12] were utilized for the development of controlled drug release systems. Among all, electrical technique provides a rapid, relatively simple and easy way to control drug release [13] .
Conducting polymers such as polypyrrole (PPy) and poly3,4-ethylenedioxythiophene (PEDOT) can be modulated by electrical stimulation to alternate their redox states which results in simultaneous changes in the polymer charges, conductivity and volume allowing to achieve controlled drug release [11, 12, 14] .
Electrical stimulation has been utilized to trigger drug release in bulk conducting polymer materials. Due to the combination of biocompatibility [15, 16] and the possibility to modulate the properties with electronic charge transfer, PPy attracted an attention for the implantable device engineering. The biodegradability of polypyrrole-based conductive composites might be tailored [17] by means of introduction of degradation sites (e.g. ester linkage) available for in vivo enzymatic cleavage. The products of polymer degradation can be consumed by macrophages during the normal wound healing response [18] .
Zinger et. al. first reported on the controlled release system based on PPy film for delivery of glutamate [19] . Thereafter, different dopants have been added to the conducting polymer to develop advanced controlled release systems for anionic, cationic and neutral drugs [13] . Hepel et. al. showed the electrically controlled delivery of chlorpromazine within a melanin-doped PPy film [20, 21] . Bidan et. al. reported using a sulphonated cyclodextrins-doped PPy film for controlled release of N-methylphenothiazine [22] .
George et. al. demonstrated the use of a biotin-doped PPy film for electrically controlled delivery of nerve growth factor (NGF) [14] . More recently, nanostructured conducting polymer-based delivery systems have been developed with improved drug delivery efficiency. Luo et. al. reported the use of nano-porous PPy films with increased active surface areas for delivery of fluorescein [23] . The nano-porous PPy film with a higher surface-areas-to-volume ratio exhibited 9 times higher release rate than the bulk planar PPy films.
Sharma et. al. developed a macroporous PPy inverse opal film with enhanced loading capacity and release capability of antipsychotic drug risperidone compared to a non-porous PPy film [24] . Beside drug molecules, the biotin-doped porous PPy film has been introduced for electrically controlled release of avidin-functionalized gold nanoparticles [25] . There is a recent reported on the use of a poly (3,4- ethylenedioxythiophene)-single walled carbon nanotubes (PEDOT-SWCNTs) composite for electrically controlled delivery of dexamethasone. The SWCNTs greatly improved the conductivity of the film and enhanced the rate of drug release compared with a pure PEDOT film [26] .
However, the reported electrically controlled drug delivery systems could only perform in bulk polymer films attached to electrode surfaces. In contrast, colloidal drug delivery systems with particulate carriers such as micelles, liposomes, nano-and microparticles have been proven to have excellent ability for drug encapsulation, controlled release and targeting delivery [27] . Different triggering mechanisms based on pH [28] , temperature [29] , light [30] , enzyme [31] , and magnetic-field [32] had been developed for controlled drug release in colloidal delivery systems. Such particle delivery systems have the advantage of small and controllable size, large surface-area-to-volume ratio for maximizing drug loading and enhanced drug release, relatively easy to produce, and more importantly highly dispersible and injectable for site-specific targeted drug delivery [33] [34] [35] . The accumulation of drug carrier reaching the targeted tissue could enhance efficiency and effectiveness of the treatment due to the localized delivery of high dosage of the drug close to the targeted tissue surface [36, 37] . Besides, drug release monitoring in colloidal drug delivery system is challenging, and most detection techniques are mainly measure the released drug in bulk solution [9] [10] [11] 14] . However, for targeted drug delivery, it is important to monitor the localized drug release within the microenvironment of the carrier system. By combining the concept of dispersed drug delivery and advance colloid electrochemistry, we have developed the first time an insitu dispersed drug release system based on conducting polymer microcapsules induced by the electrode potential ( Figure 1A ). The redox conversion of microcapsules colloid solution was accompanied by delayed ionic equilibration yielding the release of methylene blue (MB) as a model ionic drug. The time-resolved discrimination of two processes has been achieved via dynamic electrochemical methods with standard glassy carbon electrode allowing drug release and fast probing of the released drug in the microenvironment. The effect of microscale wall morphology on the conducting polymer capsules and drug release behavior were investigated.
Materials and Methods

Materials
Calcium chloride (CaCl 2), copper (II) perchlorate (Cu(ClO4)2•6H2O), sodium carbonate (Na2CO3), ethylenediaminetetracetic acid (EDTA), ethanol, 2-propanol, methylene blue (MB) and pyrrole (99%) were purchased from Sigma-Aldrich and were used as received. Pyrrole (99%) was further purified before use by passing through a neutral column of alumina (0.05 nm) to obtain a colorless liquid. Water was purified using a Milli-Q water purification system.
Fabrication of the MB-loaded PPy microparticle drug carrier
PPy microparticles (PPyMP) were prepared by hard template polymerization as reported previously [38] .
In brief, 1 mL of CaCl2 (0.5 M) and 1 mL of Na2CO3 (0.5 M) were rapidly mixed at 600 r.p.m. and kept under stirring for 30 seconds to produce calcium carbonate (CaCO3) microparticles as a template. CaCO3 microparticles were washed twice with water consecutively, followed by washing with ethanol and 2- 
Particle size and zeta potentials analysis
The particle size and zeta potential (surface charge) of the microparticles in solution were measured using a Zetasizer Nano ZS90 (Malvern Instruments Ltd., Worcestershire, UK). The particle size was measured based on a dynamic light scattering technique, measuring the Brownian motion of the particles and converting the data into a size distribution graph using the Stokes-Einstein relationship. The zeta potential measurement is based on laser Doppler micro-electrophoresis principle. The electrophoretic mobility (μ) was converted to the zeta-potential (ζ) using the Smoluchowski relation ζ = μη / ε, where η and ε are the viscosity and permittivity of the solution respectively. 1 mL of suspended microparticles in PBS solution was loaded into a zeta potential measuring cell. The measurements were performed at 25 ºC and the mean zeta potential values were calculated by taking an average of 3 repeated measurements.
Electrochemical measurements
All electrochemical experiments were performed with a PGSTAT30 potentiostat (Autolab, Netherlands) under NOVA or GPES software control employing a conventional three-electrode electrochemical cell. All experiments were performed in aqueous media (10 mM PBS pH 7.4). The oxygen background effect was eliminated by bubbling nitrogen for 15 minute. All the measurements have been carried out under nitrogen blanket. The glassy carbon electrode (GCE, 3 mm diameter with a surface area (electrode footprint) of 0.0707 cm2 was utilized for the current densities calculations) was used as the working electrode, a platinum wire as the auxiliary electrode, and a silver/silver chloride electrode as the reference electrode (3M KCl). Prior to use, the working electrode was successively polished with 1.0, 0.3 and 0.05 µm alumina powders and sonicated in water for 10 min after each polishing step. Finally, the electrode was washed with ethanol and then dried with a high purity argon stream. The GCE was modified with PPyMP by drop-casting of aqueous solutions followed by curing at 60 ºC for 30 min. Potential modulation of MB-loaded PPyMP were performed by using GCE modified with drop-casting of MB-loaded PPyMP or measuring the MB-loaded PPyMP stable colloidal solution. The positive charge results from the protonated nitrogen atom of polypyrrole at pH 7.4 [34] and from monocationic form of MB (pKa ~5.6).
Electrochemical characterizations
The effect of the structural organization on the material characteristics of drug storage and release was investigated first by cyclic voltammetry at glassy carbon electrode (GCE) modified with the same loading mass (50 μg calculated from the dry weight) of the MB-loaded PPyMPs with different morphologies, while having similar chemical composition, surface zeta potential and physical diameter. A change in the electronic charge due to the oxidation and reduction processes of the conducting polymers is accompanied by an equivalent change in the ionic charge for the electroneutrality maintaining, which requires ionic mass transport between the polymer and electrolyte [10, 39] yielding the volume change [40] . The magnitude of expansion and contraction depends on the number and size of transferred ions [41] opening wide possibilities for the applications [42] , e.g. for controllable drug release [1] and microfluidic pumps [43] .
The MB storage capacity of developed materials has been studied by cyclic voltammetry with electrodes modified with drop-casted films fabricated from thin-, medium and thick-hollow MB-loaded PPyMPs ( Figure. 2). On the contrast to buffer, the presence of MB-loaded PPyMPs in the solution led to the appearance of MB reversible redox process at -0.3 V and slightly larger capacitive currents. Moreover, the solutions became blue after the measurements. These facts illustrate the presence of the MB inside the PPyMPs available for the release by the applied potential during voltammetry experiment. The scan rate study ( Figure. 1S) showed a surface-confined behavior of observed MB redox process due to the adsorption of released monocation drug onto GCE surface [44] .
In order to decouple the contributions from PPy and MB into the voltammetric response of the filmmodified electrodes the measurements were carried out in acidic media ensuring higher PPy conductivity ( Figure 2S ). The well-defined couple of peaks associated with MB redox reaction is visible over the boxshaped electrocapacitive voltammogram of PPy allowing the estimation of the background-subtracted charges under the MB redox peaks obtained at low scan rate (5 mV/s). The MB-doped thin-, medium-and thick-wall hollow PPyMP films showed the values of 0.19 mC, 0.14 mC and 0.1 mC, respectively. Assuming two electron MB redox process and knowing the masses of films, the values of MB content were estimated as 0.66%, 0.53% and 0.40% for thin-, medium-and thick-wall hollow PPyMP. Having the largest inner cavity, the thin-wall hollow microparticles synthesized during short reaction time (1 hour) showed the largest MB content. Therefore, the main storage domain of the host material is the inner cavity of the hollow microparticle. MB remains intact and available for the release from PPy polymerized in mild conditions.
Potential-induced drug released and fast probing of released drug
In order to get the insight into the mechanism of the observed potential-induced drug release the dynamic electrochemical methods, i.e. double step chronocoulometry and fast voltammetry, have been utilized for the studies of MB-loaded PPyMP colloid solutions. In order to prevent the passive leakage of MB from the carrier microparticles due to concentration gradient the concentrated colloid solutions have been washed by centrifugation with PBS buffer just before the addition into the electrochemical cell. No turbidity was observed after the introduction of MB-loaded PPyMP into the measurement cell illustrating the stability of colloid solution.
First modulation pulse of the double-step chronocoulometry was utilized in order to affect the colloid solution of microparticles, which might lead to the drug release due to the appearance of ionic flow to equilibrate the change in the electronic charge of the particles. The modulation pulse of applied potential should trigger the complex phenomena in colloid solution appeared in a close vicinity to the working electrode surface. Firstly, after the fast relaxation of double layer on electrode surface the applied potentials should lead to the electronic charge change of the conducting polymer microparticles. Secondly, the ionic charge should appear as a response to the first process in order to maintain electroneutrality of the material resulting in the possible drug release. Both electronic and ionic current flows should be timeresolved due to the general difference in the rates. The second pulse of the double-step chronocoulometry was designed to detect the changes in the microenvironment caused by the modulation pulse. efficiencies, which might be a result of two effects related to electronic and ionic processes: increase of electronic conductivity of MB-loaded PPyMP [45] and the presence of MB undergoing subsequent faradaic reactions on the working electrode surface:
where LMB is a fully reduced leuco-MB. The possible monoelectronic reduction caused the appearance of a variety of intermediates stable on the electrode surface [44] .
In order to distinguish electronic and ionic processes the modulation time dependence has been studied ( Figure. 3B ). The increase of charge with increase of modulation time is shown for all measurements illustrating the charge transfer kinetics of modulation detectable at the second pulse. Higher amplitudes of modulation potential led to the larger detectable charges showing increase of charge injection efficiency with polarization increase. The short times of the modulation (from 0.5 ms to 0.1 s) are characterized with the increase of detectable charges followed by the saturation at longer times of modulation pulse (1-10 s). The saturation threshold observed for all modulation pulses probably illustrate the appearance of the diffusion of the converted forms of colloid material from the electrode surface.
Importantly, the charge detected at the long modulation pulse of large anodic amplitude (0.7 V) revealed the prominent dependence on the potential of the detection pulse (Inset in Figure 3B ) In order to confirm the effect by independent measurements the modulation pulse has been followed by fast voltammetry measurements as a detection step ( Figure 5 ). The comparison of voltammograms obtained in the colloid solution of MB-loaded PPyMP before and after modulation pulse of high anodic amplitude (0.7 V) showed the appearance of redox peak currents of MB illustrating the presence of MB released into the buffer. The fast voltammetry allowed the visualization of the released drug, which diffused away due to the concentration gradient disabling the detection with slower scan rates.
Importantly, the thin-wall hollow MB-doped showed the largest redox currents of the drug, while the medium-wall hollow microparticles showed significantly smaller peaks. The thick-wall hollow microparticles showed the absence of the MB redox signal. Therefore, in consistency with drop-casted films the measurements performed with a colloid solution confirmed the microscale morphology control of the amount of loaded drug, which is available of potential-induced release.
Conclusion
In conclusion, we demonstrated the feasibility for precision control of drug release from dispersed electroresponsive microcapsules triggered by in-situ colloids electrochemistry occurring at the electrode surface, while the bulk colloids dispersion away from the electrode surface remains as a drug reservoir, thus improving the efficiency of localized drug release at the target location. The dynamic electrochemical measurements allow the distinction of drug release associated with ionic relaxation and the change of electronic charge of conducting polymer microparticles. The developed new methodology creates a model platform for the investigations of surface potential-induced in-situ release mechanism with a long term vision on development of a direct controlled drug release system for biological objects driven by cell surface potentials. 
